Headquartered in Madison, WI Fiscal year ends June NASDAQ: ARAY accuray.com
Accuray Incorporated (NASDAQ: ARAY) develops and sells radiation therapy systems for oncology and neuro-radiosurgery treatments. The company designs market-changing solutions to deliver radiation treatments for complex and commonly treatable cases across the full spectrum of patient needs. Accuray generates revenue through two streams: product sales of its radiation therapy systems and recurring service revenue from maintenance contracts and support for its installed base. The company partners with clinicians and administrators globally and has been expanding its strategic partnership ecosystem across imaging, software, engineering, adaptive therapy, research, and customer support. Accuray also operates through a China joint venture and serves customers in international markets that are subject to geopolitical and trade policy risks. Updated
These are five stocks for aggressive investors looking to get share count leverage on companies that have sizable upside potential. While not suited for all investors, they are not penny stocks with…
The top analyst upgrades, downgrades and other research calls from Wednesday include American Electric Power, Bank of America, Citigroup, Equinix, JD.com, Ralph Lauren and Sensata Technologies.
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include CONSOL Energy, Kroger, 3M, NVIDIA, Qualcomm and Xilinx.
Despite the markets hitting all-time high, insiders continued to buy stock this past week, in what could be a very bullish sign for investors.
ThinkstockOnce again, the Wall Street conference calendar is heating up. Next week is the widely attended Jefferies Global Healthcare Conference in New York City. Following the success of last year’s conference, with…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street research calls this Monday morning. Alliance Data Systems Corporation (NYSE: ADS) Cut to Market Perform at…
Active traders and day traders have many stocks to choose from this Wednesday morning. We are tracking news and moves in shares of Acuray Incorporated, Inc. (NASDAQ: ARAY), BSD Medical corporation (NASDAQ: BSDM), Cypress Bioscience…
Douglas A. McIntyre Today’s BioHealth Business Daily is full of some of the names you might expect to see, but it also has some unusual names as well. We are seeing share price moves in…
These are this Tuesday’s top day trader and active trader alerts with more detailed price and volume data and analysis provided by links to each story at VSInvestor.com: Accuray Incorporated (NASDAQ: ARAY)…
These are some of the top pre-market analyst upgrades and positive calls we have seen on Wall Street this Friday morning: Accuray (ARAY) Raised to Buy at Piper Jaffray. AstraZeneca (AZN) Raised…
Cadence Design Systems (CDNS) posts bad numbers and gets downgrades. Falls to $9.90 from 52-week high of $24.90. Accuray (ARAY) The radiosurgery device maker reported disappointing fiscal second-quarter results. Trades off to…
Accuray Inc. (NASDAQ: ARAY) is being punished in after-hours trading. The company posted earnings at $0.04 EPS on revenues of $52 million. The problem is that First Call was at $0.09 EPS…
Douglas A. McIntyre Accuray (ARAY) Radiosurgery company has quarterly loss. Down to $12.90 from 52-week high of $31.09. Home Solutions (HSOA) Problems with credit facility. Down to $2.85 from 52-week high of $8.24. Tarragon (TARR)…
Douglas A. McIntyre Accuray Incorporated (NASDAQ: ARAY) develops and sells radiation therapy systems for oncology and neuro-radiosurgery treatments. The company designs market-changing solutions to deliver radiation treatments for complex and commonly treatable cases across the full spectrum of patient needs.
The Wall Street consensus 12-month price target for ARAY is $0.35.
